RVNC Annual Net Income
-$323.99 M
+$32.44 M+9.10%
31 December 2023
Summary:
As of January 20, 2025, RVNC annual net profit is -$323.99 million, with the most recent change of +$32.44 million (+9.10%) on December 31, 2023. During the last 3 years, it has fallen by -$41.90 million (-14.85%). RVNC annual net income is now -622.17% below its all-time high of -$44.86 million, reached on December 31, 2011.RVNC Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVNC Quarterly Net Income
-$38.12 M
-$641.00 K-1.71%
30 September 2024
Summary:
As of January 20, 2025, RVNC quarterly net profit is -$38.12 million, with the most recent change of -$641.00 thousand (-1.71%) on September 30, 2024. Over the past year, it has increased by +$103.06 million (+73.00%). RVNC quarterly net income is now -329.08% below its all-time high of -$8.88 million, reached on September 30, 2013.RVNC Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVNC TTM Net Income
-$184.44 M
+$103.06 M+35.85%
30 September 2024
Summary:
As of January 20, 2025, RVNC TTM net profit is -$184.44 million, with the most recent change of +$103.06 million (+35.85%) on September 30, 2024. Over the past year, it has increased by +$229.74 million (+55.47%). RVNC TTM net income is now -1591.95% below its all-time high of -$10.90 million, reached on December 31, 2012.RVNC TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVNC Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.1% | +73.0% | +55.5% |
| 3 y3 years | -14.8% | +48.8% | +37.8% |
| 5 y5 years | -127.3% | +8.0% | -15.7% |
RVNC Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -15.2% | +9.1% | -1.7% | +73.9% | at high | +55.5% |
| 5 y | 5-year | -103.2% | +9.1% | -1.7% | +73.9% | -15.7% | +55.5% |
| alltime | all time | -622.2% | +9.1% | -329.1% | +73.9% | -1592.0% | +55.5% |
Revance Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$38.12 M(+1.7%) | -$184.44 M(-35.8%) |
| June 2024 | - | -$37.47 M(-29.5%) | -$287.50 M(-9.4%) |
| Mar 2024 | - | -$53.15 M(-4.6%) | -$317.28 M(-2.1%) |
| Dec 2023 | -$323.99 M(-9.1%) | -$55.70 M(-60.5%) | -$323.92 M(-21.8%) |
| Sept 2023 | - | -$141.18 M(+109.9%) | -$414.18 M(+15.8%) |
| June 2023 | - | -$67.25 M(+12.5%) | -$357.69 M(+1.6%) |
| Mar 2023 | - | -$59.79 M(-59.0%) | -$352.20 M(-1.3%) |
| Dec 2022 | -$356.42 M(+26.7%) | -$145.95 M(+72.3%) | -$356.75 M(+30.3%) |
| Sept 2022 | - | -$84.69 M(+37.1%) | -$273.89 M(+3.9%) |
| June 2022 | - | -$61.76 M(-4.0%) | -$263.58 M(-3.8%) |
| Mar 2022 | - | -$64.34 M(+2.0%) | -$274.01 M(-2.6%) |
| Dec 2021 | -$281.31 M(-0.3%) | -$63.10 M(-15.2%) | -$281.31 M(-5.1%) |
| Sept 2021 | - | -$74.38 M(+3.0%) | -$296.52 M(-2.3%) |
| June 2021 | - | -$72.20 M(+0.8%) | -$303.40 M(+4.0%) |
| Mar 2021 | - | -$71.64 M(-8.5%) | -$291.80 M(+3.4%) |
| Dec 2020 | -$282.09 M(+76.9%) | -$78.31 M(-3.6%) | -$282.09 M(+13.2%) |
| Sept 2020 | - | -$81.26 M(+34.1%) | -$249.11 M(+19.0%) |
| June 2020 | - | -$60.59 M(-2.2%) | -$209.26 M(+12.5%) |
| Mar 2020 | - | -$61.93 M(+36.6%) | -$186.06 M(+16.7%) |
| Dec 2019 | -$159.43 M(+11.8%) | -$45.33 M(+9.5%) | -$159.43 M(+3.0%) |
| Sept 2019 | - | -$41.41 M(+10.7%) | -$154.72 M(+5.9%) |
| June 2019 | - | -$37.39 M(+5.9%) | -$146.14 M(+2.3%) |
| Mar 2019 | - | -$35.30 M(-13.1%) | -$142.83 M(+0.2%) |
| Dec 2018 | -$142.57 M | -$40.62 M(+23.7%) | -$142.57 M(+3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$32.83 M(-3.7%) | -$137.86 M(+1.6%) |
| June 2018 | - | -$34.08 M(-2.7%) | -$135.68 M(+5.6%) |
| Mar 2018 | - | -$35.04 M(-2.4%) | -$128.47 M(+6.5%) |
| Dec 2017 | -$120.59 M(+35.1%) | -$35.91 M(+17.1%) | -$120.59 M(+8.2%) |
| Sept 2017 | - | -$30.65 M(+14.1%) | -$111.48 M(+12.8%) |
| June 2017 | - | -$26.87 M(-1.0%) | -$98.81 M(+2.4%) |
| Mar 2017 | - | -$27.16 M(+1.3%) | -$96.54 M(+8.1%) |
| Dec 2016 | -$89.27 M(+21.5%) | -$26.80 M(+49.1%) | -$89.27 M(+5.6%) |
| Sept 2016 | - | -$17.98 M(-26.9%) | -$84.56 M(-1.4%) |
| June 2016 | - | -$24.60 M(+23.7%) | -$85.76 M(+10.0%) |
| Mar 2016 | - | -$19.89 M(-10.0%) | -$77.96 M(+6.1%) |
| Dec 2015 | -$73.48 M(+16.8%) | -$22.09 M(+15.2%) | -$73.48 M(+12.0%) |
| Sept 2015 | - | -$19.18 M(+14.1%) | -$65.59 M(+8.6%) |
| June 2015 | - | -$16.80 M(+9.1%) | -$60.40 M(+6.2%) |
| Mar 2015 | - | -$15.40 M(+8.4%) | -$56.89 M(-9.6%) |
| Dec 2014 | -$62.92 M(+20.0%) | -$14.21 M(+1.7%) | -$62.92 M(+7.0%) |
| Sept 2014 | - | -$13.98 M(+5.1%) | -$58.78 M(+9.5%) |
| June 2014 | - | -$13.30 M(-37.9%) | -$53.69 M(+2.8%) |
| Mar 2014 | - | -$21.43 M(+112.6%) | -$52.22 M(-0.4%) |
| Dec 2013 | -$52.45 M(-10.0%) | -$10.08 M(+13.5%) | -$52.45 M(-1.5%) |
| Sept 2013 | - | -$8.88 M(-24.9%) | -$53.27 M(+20.0%) |
| June 2013 | - | -$11.83 M(-45.4%) | -$44.39 M(+36.3%) |
| Mar 2013 | - | -$21.66 M(+98.7%) | -$32.56 M(+198.7%) |
| Dec 2012 | -$58.26 M(+29.9%) | -$10.90 M | -$10.90 M |
| Dec 2011 | -$44.86 M | - | - |
FAQ
- What is Revance Therapeutics annual net profit?
- What is the all time high annual net income for Revance Therapeutics?
- What is Revance Therapeutics annual net income year-on-year change?
- What is Revance Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Revance Therapeutics?
- What is Revance Therapeutics quarterly net income year-on-year change?
- What is Revance Therapeutics TTM net profit?
- What is the all time high TTM net income for Revance Therapeutics?
- What is Revance Therapeutics TTM net income year-on-year change?
What is Revance Therapeutics annual net profit?
The current annual net income of RVNC is -$323.99 M
What is the all time high annual net income for Revance Therapeutics?
Revance Therapeutics all-time high annual net profit is -$44.86 M
What is Revance Therapeutics annual net income year-on-year change?
Over the past year, RVNC annual net profit has changed by +$32.44 M (+9.10%)
What is Revance Therapeutics quarterly net profit?
The current quarterly net income of RVNC is -$38.12 M
What is the all time high quarterly net income for Revance Therapeutics?
Revance Therapeutics all-time high quarterly net profit is -$8.88 M
What is Revance Therapeutics quarterly net income year-on-year change?
Over the past year, RVNC quarterly net profit has changed by +$103.06 M (+73.00%)
What is Revance Therapeutics TTM net profit?
The current TTM net income of RVNC is -$184.44 M
What is the all time high TTM net income for Revance Therapeutics?
Revance Therapeutics all-time high TTM net profit is -$10.90 M
What is Revance Therapeutics TTM net income year-on-year change?
Over the past year, RVNC TTM net profit has changed by +$229.74 M (+55.47%)